Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 297 - 304 of 11617 results
Patent Ruling Shows a Minor Typo Can Lead to a Major Loss
July 17, 2024| News
PAGA’s Reforms Aim to Deliver on Its Original Promise
July 17, 2024| News
Navigating the Post-Chevron Landscape at FERC: What Clean Energy Companies Really Need to Know
July 16, 2024| Webinar| Viewpoint
Mintz IRA Update — Third Edition: Q2 2024
July 15, 2024| Blog| Viewpoint
Mintz IRA Update — Learning From Experience: Medicare Drug Price Negotiation Program Updates
July 15, 2024| Blog| Viewpoint
Mintz IRA Update — The Consequences and Costs of Redesigning the Part D Program
July 15, 2024| Blog| Viewpoint
Mintz IRA Update — Opposition to the Use of March-In Rights to Lower Drug Prices
July 15, 2024| Blog| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.